AI helps create tiny immune helpers to fight inflammation

Scientists are now using artificial intelligence to design small protein rings that can fine-tune the body’s immune responses. These rings, called cyclic peptides, act like tiny light switches for immune cells. Instead of turning lights on or off, they control whether immune cells get activated or stay quiet. One of these peptides, named CIP-3, sticks to a specific immune checkpoint protein called CD28. It clings so tightly that it blocks signals that normally activate immune cells. This is important because overactive immune cells can cause problems like chronic inflammation or autoimmune diseases. Unlike many current treatments that stay in the body for a long time, CIP-3 works fast and its effects fade quickly once it’s gone. That means doctors could adjust the dose to control immune activity without long-term side effects.

In lab tests with human immune cells, CIP-3 showed it could calm down immune responses without accidentally turning them up. It worked in cells from healthy people and from patients with ulcerative colitis, a disease where the immune system attacks the gut. The peptide performed just as well as existing antibody treatments but with an advantage: it doesn’t stick around too long. In animal models of colitis, higher doses of CIP-3 led to less inflammation, proving it could be a real treatment option. The real breakthrough here is the use of AI to design these peptides. Normally, finding new drugs is slow and expensive. But AI can test millions of protein shapes in a computer before scientists even mix a single chemical in a lab. This speeds up the process and makes it easier to find drugs that target specific parts of the immune system. The fact that CIP-3 works so precisely—and reversibly—could open doors to safer, smarter treatments for diseases caused by an overactive immune system.

Actions